Treatment of Newly Diagnosed Ovarian Cancer With Antioxidants
The purpose of this study is to try and understand if there is added benefit or increased harm when antioxidant nutritional supplements are added to traditional chemotherapy in the treatment of ovarian cancer.
Ovarian Cancer
DIETARY_SUPPLEMENT: Oral Ascorbic Acid|DRUG: Paclitaxel|DRUG: Carboplatin|DRUG: Sodium Ascorbate|DIETARY_SUPPLEMENT: Oral Mixed natural Carotenoids with Vitamin A|DIETARY_SUPPLEMENT: Vitamin E
Adverse events by NCI CTC version 3.0, At each oncology clinic visit
Quality of Life Questionnaire, once a month for 6 months and the end of the study|Blood chemistry, At each oncology clinic visit|CA-125 analysis, At each oncology clinic visit|complete CBC with differential, At each oncology clinic visit
The subjects are randomized to 2 study groups. Group 1 receives standard chemotherapy prescribed by the cancer doctor (carboplatin and paclitaxel)with a possible choice to extend chemotherapy for up to an additional 12 months.

Group 2 receives standard chemotherapy in the same manner as group 1. In addition, they receive 12 months of oral or IV nutritional supplements.